Aricate Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-01-2025
- Paid Up Capital ₹ 0.10 M
as on 10-01-2025
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.88 Cr
as on 10-01-2025
- Revenue %
(FY 2020)
- Profit 36.96%
(FY 2020)
- Ebitda 35.43%
(FY 2020)
- Net Worth -15.13%
(FY 2020)
- Total Assets -14.57%
(FY 2020)
About Aricate Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.88 Cr.
Nitin Bhayana and Umesh Kalra serve as directors at the Company.
- CIN/LLPIN
U24304PB2018PTC048754
- Company No.
048754
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Patiala, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aricate Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Bhayana  | Director | 12-Dec-2018 | Current |
| Umesh Kalra | Director | 12-Dec-2018 | Current |
Financial Performance of Aricate Formulations.
Aricate Formulations Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 36.96% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aricate Formulations?
In 2020, Aricate Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Jun 2023 | ₹5.88 Cr | Open |
How Many Employees Work at Aricate Formulations?
Unlock and access historical data on people associated with Aricate Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aricate Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aricate Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
